Harper Molly
Catalyst Pharmaceuticals, Inc. · Director
Harper Molly is listed in filings as Director at Catalyst Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Dec 30, 2025, including sale activity. Recent filings connect the profile to Catalyst Pharmaceuticals, Inc. (CPRX). The current snapshot covers public activity from Nov 29, 2024 to Dec 30, 2025. Reported amounts are shown as $360.2K to $115.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $360k15.5k shares | SellDec 12, 2025 | $23.20 | $31.49 | |
| $156k6.7k shares | SellDec 12, 2025 | $23.06 | $31.49 | |
| $106k4.5k shares | SellDec 12, 2025 | $23.73 | $31.49 |